Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00412347 · ClinicalTrials.gov registry record
Insulin Infusion in the Hospital Wards
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 200
- Enrollment target
NCT00412347 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 200 participants.
The verdict
NCT00412347 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
Increasing evidence from clinical studies in Intensive Care Unit (ICU) settings indicates that insulin infusion can improve outcome measures for patients with hyperglycemia (high blood sugar) independent of a previous diagnosis of diabetes mellitus. This improvement in health could also apply to patients that have high blood sugars in various other non-critical care areas of the hospital as well. However, the data that shows improvement in health outcomes has been collected from wards that have a lower patient to provider and patient to nurse ratio, resulting in the ability for a much tighter control of the insulin infusion. We hypothesize that tight blood glucose control will provide the same benefits for patients in non-intensive care units settings but that these protocols may lead to a higher incidence of hypoglycemia (low blood sugar) and potentially to adverse outcomes in patients. This study aims to determine the clinical outcome of patients treated with insulin infusion as well as the rate of hypoglycemic episodes in non-intensive areas. We will conduct a chart review of patients treated with insulin infusions in non-critical wards at Emory University Hospital during the period of 7/1/04 to 6/30/05. Medical records of all patients treated with intravenous insulin infusion protocols will be analyzed. Data on demographics, laboratory values, mortality rate, rate of hypoglycemic events, length of stay, as well as disposition at discharge will be analyzed.
Interventions
- DRUG Insulin Drip Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2006-08 |
| Est. Completion | 2006-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00412347
The ClinicalTrials.gov registry entry for NCT00412347 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Insulin Drip Therapy is the first listed.
NCT00412347 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00412347 about?
NCT00412347 is a clinical study titled "Insulin Infusion in the Hospital Wards". Increasing evidence from clinical studies in Intensive Care Unit (ICU) settings indicates that insulin infusion can improve outcome measures for patients with hyperglycemia (high blood sugar) independent of a previous diagnosis of diabetes mellitus. This improvement in health could also apply to pat...
What is the current status of trial NCT00412347?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2006-08. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00412347?
The interventions under investigation include: Insulin Drip Therapy (DRUG).
Who is sponsoring clinical trial NCT00412347?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.